neonatal renal failure
Recently Published Documents


TOTAL DOCUMENTS

17
(FIVE YEARS 1)

H-INDEX

8
(FIVE YEARS 0)

Cureus ◽  
2021 ◽  
Author(s):  
Wendy Jo Svetanoff ◽  
Asma Ahmed ◽  
Richard J Hendrickson ◽  
Rebecca M Rentea

2017 ◽  
Vol 4 (4) ◽  
pp. 1549
Author(s):  
Poonam Agrawal ◽  
Manas Upadhyay ◽  
Rajlaxmi Upadhyay ◽  
Saroj Kumar Satpathy

Telmisartan is an antihypertensive medication, which acts as an angiotensin II receptor blocker, and has an inhibitory effect on the renin-angiotensin system. Angiotensin receptor blockers(ARBs) are contraindicated in pregnancy (category D); adverse effects have been reported in both animal and human pregnancies, but still pregnant mothers do come with this medication with consequent neonatal adverse complications. We report 2 such cases of adverse neonatal outcomes in hypertensive mothers exposed to Telmisartan during pregnancy.


NeoReviews ◽  
2016 ◽  
Vol 17 (12) ◽  
pp. e744-e752
Author(s):  
Cynthia J. Wong

2016 ◽  
Vol 7 ◽  
pp. 8-10 ◽  
Author(s):  
Carole Harbulot ◽  
Stéphanie Paquay ◽  
Imen Dorboz ◽  
Samia Pichard ◽  
Agnès Bourillon ◽  
...  

Medicine ◽  
2015 ◽  
Vol 94 (7) ◽  
pp. e469 ◽  
Author(s):  
Maria Inês Alvelos ◽  
Magda Rodrigues ◽  
Luísa Lobo ◽  
Ana Medeira ◽  
Ana Berta Sousa ◽  
...  

2014 ◽  
Vol 24 (4) ◽  
pp. 249 ◽  
Author(s):  
M Sahay ◽  
K Ismal ◽  
PS Vali ◽  
D Saivani

2011 ◽  
Vol 30 (4) ◽  
pp. 266-272 ◽  
Author(s):  
Larissa V. Furtado ◽  
Theodore Pysher ◽  
John Opitz ◽  
Randy Lamb ◽  
Jessica Comstock ◽  
...  

2005 ◽  
Vol 17 (3) ◽  
pp. 235-237 ◽  
Author(s):  
Srinivas Murki ◽  
Praveen Kumar ◽  
Sourabh Dutta ◽  
Anil Narang

2004 ◽  
Vol 19 (2) ◽  
pp. 232-234 ◽  
Author(s):  
Daniela Benini ◽  
Vassilios Fanos ◽  
Laura Cuzzolin ◽  
Luciano Tat�

2003 ◽  
Vol 18 (9) ◽  
pp. 887-893 ◽  
Author(s):  
Brenda Montan� ◽  
Jayanthi Chandar ◽  
Shahnaz Duara ◽  
Gast�n Zilleruelo ◽  
Carolyn L. Abitbol ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document